STOP-ALLERG EYE DROPS contains sodium cromoglycate as an active substance. It belongs to a group of medicines called anti-allergenics.
STOP-ALLERG EYE DROPS is used to treat and relieve these signs of eye allergies.
STOP-ALLERG EYE DROPS contains sodium cromoglycate as an active substance. It belongs to a group of medicines called anti-allergenics.
STOP-ALLERG EYE DROPS is used to treat and relieve these signs of eye allergies.
Do not take STOP-ALLERG EYE DROPS:
Special care should be taken with STOP-ALLERG EYE DROPS:
Always tell your healthcare provider if you are taking any other medicine. (This includes all complementary or traditional medicines.)
No interactions known.
Safety in pregnancy, lactation and fertility has not been established. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist, or other health care provider for advice before taking this medicine.
Transient stinging, burning or blurred vision may occur after instillation of STOP-ALLERG Eye drops. Do not drive or operate machinery until proper vision is restored. It is not always possible to predict to what extent STOP-ALLERG EYE DROPS may interfere with the daily activities of a patient. Patients should ensure that they do not engage in the above activities until they are aware of the measure to which STOP - ALLERG EYE DROPS affects them.
Do not share medicines prescribed for you with any other person.
Always take STOP-ALLERG EYE DROPS exactly as described in this leaflet or as your doctor, pharmacist, or nurse if you are not sure.
The usual dose: For adults (including the elderly) and children: 1-2 drops into each eye 4 times daily. STOP-ALLERG EYE DROPS should be used regularly to ensure optimal control of symptoms. It is recommended that treatment is continued during the period to the allergen, even when free of symptoms.
For ophthalmic use only. Care should be taken to avoid contamination of the contents during use. Patient should be advised not to wear soft contact lenses during treatment with STOP-ALLERG EYE DROPS.
If you use more STOP-ALLERG EYE DROPS than you should
In the event of an overdosage, or if someone has accidentally swallowed STOP- ALLERG EYE DROPS, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre.
If you forget to take STOP-ALLERG EYE DROPS
Do not take / receive a double dose to make up for forgotten individual doses.
STOP-ALLERG EYE DROPS can have side effects. Not all side effects reported for STOP-ALLERG EYE DROPS are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking STOP-ALLERG EYE DROPS, please consult your health care provider for advice.
If any of the following happens, stop taking / using STOP-ALLERG EYE DROPS and tell your doctor immediately or go to the casualty department at your nearest hospital:
These are all very serious side effects. If you have them, you may have had a serious reaction to STOP- ALLERG EYE DROPS. You may need urgent medical attention or hospitalisation.
Tell your doctor if you notice any of the following side effects:
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Reporting of side effects
If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of STOP - ALLERG EYE DROPS.
You may also report to Adcock Ingram Limited using the following email: [email protected]
Store all medicines out of reach of children.
Store at or below 25 °C.
Protect from light.
Do not use after the expiry date stated on the label / carton / bottle.
Discard 30 days after opening.
Return all unused medicine to your pharmacist.
Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).
The Stop-Allerg Eye 2,0 % Solution professional information leaflet below is the property of Adcock Ingram Limited and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
The patient information text is available above. Load the original PDF only when you need it.